We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2010 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01114867
First Posted: May 3, 2010
Last Update Posted: March 27, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Tel-Aviv Sourasky Medical Center
  Purpose
Hypothesis: Measurement of fetal penis length by ultrasound may be inaccurate when measured from the scrotum to the penile tip. we will provide normal values of penile length measured from the penile tip to the abdominal wall and measuring the corpus cavernosum length.

Condition
Fetal Penis Length

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prospective Cross-sectional Study of Fetal Penis and Corpus Cavernosum Length

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment: 200
Study Start Date: October 2010
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Weeks to 34 Weeks   (Child)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Fetuses of healthy pregnant women
Criteria

Inclusion Criteria:

  • pregnant women at 14th through 34th week gestation,
  • routine ultrasound not preformed for anomalies at the genitourinary system,
  • estimated fetal weight corresponds to gestational age.

Exclusion Criteria:

  • women who's fetuses are suspected to be with fetal growth retardation,
  • women who's fetuses are suspected to be with genitourinary anomaly.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01114867


Locations
Israel
Ultrasound Unit in OBGYN, Soraski Medical Center Not yet recruiting
Tel-Aviv, Israel, 64239
Contact: Yoseph Hartoov, Dr    +972-3-6925747      
Contact: Arnon Agmon, Dr    +972-3-6925747    arnon@arnonagmon.com   
Principal Investigator: Yoseph Hartoov, Dr         
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Yoseph Hartoov, Dr Tel-Aviv, Soraski Medical Center
  More Information

Responsible Party: Yoseph Hartoov / Dr, Sorasky Medical Center
ClinicalTrials.gov Identifier: NCT01114867     History of Changes
Other Study ID Numbers: TASMC-10-YH-0128-CTIL
First Submitted: April 29, 2010
First Posted: May 3, 2010
Last Update Posted: March 27, 2014
Last Verified: April 2010

Keywords provided by Tel-Aviv Sourasky Medical Center:
ultrasound
penis length
corpus cavernosum
length of fetal penis and fetal corpus cavernosum


To Top